Drug intelligence / Profile preview

aluminum-curcumin complex

Development stage
Preclinical
Modality
Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Aluminum-curcumin complex is a metal-curcumin coordination compound where curcumin forms a chelate with aluminum ions. This complex represents an emerging therapeutic approach to enhance the pharmacological properties of curcumin, a natural compound derived from turmeric. Metal-curcumin complexes generally improve upon native curcumin's limitations including poor water solubility, low bioavailability, rapid metabolism, and quick systemic elimination. The aluminum-curcumin complex has demonstrated enhanced **anticancer efficacy** compared to curcumin alone, particularly in colorectal cancer models. The complex works by modulating apoptotic pathways, significantly decreasing expression of anti-apoptotic genes (telomerase, Bcl-2, miRNA-21) while increasing pro-apoptotic genes (BAX, miRNA-122, FASLG). The mechanism involves aluminum's ability to stimulate the immune system, creating a synergistic effect with curcumin's inherent anti-inflammatory and antioxidant properties. Additionally, curcumin can chelate aluminum ions to reduce aluminum toxicity, demonstrating neuroprotective effects by preventing aluminum-induced oxidative stress and cognitive impairment.

Other names
ACCaluminum curcuminaluminum-curcumin
02

Targets

BAX (Apoptosis regulator BAX)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CCND1 (Cyclin D1)MMP9 (Matrix metalloproteinase-9)TERT (Telomerase)miR-21 (microRNA-21)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on aluminum-curcumin complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aluminum-curcumin complex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call